Literature DB >> 17127264

Phytate acts as an inhibitor in formation of renal calculi.

Felix Grases1, Bernat Isern, Pilar Sanchis, Joan Perello, Jose Juan Torres, Antonia Costa-Bauza.   

Abstract

The aim of this study was to assess the inhibitory action of phytate in formation of renal calculi. Hypertension (induced by nicotine) combined with hypercalcemia (induced by D vitamin) was used to induce calcification in renal tissue in male Wistar rats that were fed a purified phytate free diet. Phytate non-treated rats developed significant calcium deposits in kidneys and papillae, as well as in kidney tubules and vessels, whereas calcium deposits were absent in control and phytate treated rats. Fragments of hydroxyapatite (HAP) calculi exhibited the capacity to induce the growth of calcium salts on their surfaces. Presence of 1.5 mg/L of phytate in the synthetic urine inhibited the formation of calcium oxalate monohydrate on HAP renal calculi in normocalciuric conditions. The findings show that the action of phytate as a crystallization inhibitor takes place both in the intrapapillary tissue and urine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17127264     DOI: 10.2741/2256

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  26 in total

1.  Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women.

Authors:  Angel A López-González; Félix Grases; Nieves Monroy; Bartolome Marí; Ma Teófila Vicente-Herrero; Fernando Tur; Joan Perelló
Journal:  Eur J Nutr       Date:  2012-05-22       Impact factor: 5.614

2.  Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.

Authors:  Saajidah Fakier; Allen Rodgers; Graham Jackson
Journal:  Urolithiasis       Date:  2019-02-14       Impact factor: 3.436

3.  Mechanisms of Stone Formation.

Authors:  Vishal N Ratkalkar; Jack G Kleinman
Journal:  Clin Rev Bone Miner Metab       Date:  2011-12

4.  First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification.

Authors:  J Perelló; P H Joubert; M D Ferrer; A Z Canals; S Sinha; C Salcedo
Journal:  Br J Clin Pharmacol       Date:  2018-10-03       Impact factor: 4.335

5.  Polyphosphates inhibit extracellular matrix mineralization in MC3T3-E1 osteoblast cultures.

Authors:  Betty Hoac; Tina Kiffer-Moreira; José Luis Millán; Marc D McKee
Journal:  Bone       Date:  2013-01-19       Impact factor: 4.398

6.  On the origin of calcium oxalate monohydrate papillary renal stones.

Authors:  Fèlix Grases; Antonia Costa-Bauzá; Carlo R Bonarriba; Enrique C Pieras; Rafael A Fernández; Adrián Rodríguez
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

7.  Dietary fibre and phytate--a balancing act: results from three time points in a British birth cohort.

Authors:  Celia J Prynne; Aine McCarron; Michael E J Wadsworth; Alison M Stephen
Journal:  Br J Nutr       Date:  2009-10-13       Impact factor: 3.718

8.  Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion.

Authors:  Rafael M Prieto; M Fiol; J Perello; R Estruch; E Ros; P Sanchis; F Grases
Journal:  Eur J Nutr       Date:  2010-01-28       Impact factor: 5.614

9.  Renal papillary calcification and the development of calcium oxalate monohydrate papillary renal calculi: a case series study.

Authors:  Fèlix Grases; Antonia Costa-Bauzá; Rafel M Prieto; Antonio Conte; Antonio Servera
Journal:  BMC Urol       Date:  2013-03-11       Impact factor: 2.264

10.  Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts.

Authors:  María del Mar Arriero; Joana M Ramis; Joan Perelló; Marta Monjo
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.